ARTICLE | Clinical News
Preotact regulatory update
February 27, 2006 8:00 AM UTC
CHMP issued a positive opinion for Preotact, a recombinant human parathyroid hormone (PTH), to treat osteoporosis in post- ...
CHMP issued a positive opinion for Preotact, a recombinant human parathyroid hormone (PTH), to treat osteoporosis in post- ...